The pharmaceutical industry’s reaction to President Trump’s executive order on drug prices? It could have been worse.Shares ...

Jefferies analyst Akash Tewari notes that new Medicare Part B & D draft guidance has been released and that Merck (MRK) and Bristol Myers (BMY) are trading down due to updated language on single ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs. Drugmakers aren't happy.

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

In an executive order Monday morning, Trump announced plans to reduce drug prices by 30 to 80%.

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...

Trump plans to lower US drug prices by 30-80%, impacting Indian generic drugmakers and multinational companies.